Semaglutide and tirzepatide can cause nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease
With semaglutide demonstrating significant weight loss and improved glycemic control, precise dosing becomes crucial in achieving these benefits
These improvements may include: Lower blood pressure Reduced blood sugar and cholesterol levels Healthier weight Semaglutide injection helps individuals achieve and maintain weight loss by controlling blood sugar levels and regulating appetite, which can contribute to better heart health
Muscle mass drives resting metabolic rate, supports joint health, improves insulin sensitivity, and becomes increasingly important for long-term weight maintenance after GLP-1 treatment ends
Compounded medications follow USP standards and state pharmacy regulations